EP2117517
SUSTAINED RELEASE ORAL DOSAGE FORMS OF A PRODRUG OF R-BACLOFEN AND METHODS OF TREATMENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.1.2008EP published:
1.6.2011EP application number:
08727550.9
EPO information:
European Patent Register
Max expiry date:
9.1.2028
Title:
SUSTAINED RELEASE ORAL DOSAGE FORMS OF A PRODRUG OF R-BACLOFEN AND METHODS OF TREATMENT
Timeline
Today
10.1.2008EP application
1.6.2011EP Publication
Owner
Name:
XenoPort, Inc.Address:
3410 Central Expressway, 95051, Santa Clara, CA, US
Inventor
Name:
KIDNEY, David, J.Address:
San Jose, CA, US
Name:
CUNDY, Kenneth, C.Address:
Redwood City, CA, US
Name:
SASTRY, SrikondaAddress:
Sunnyvale, CA, US
Name:
LEUNG, ManshiuAddress:
Daly City, CA, US
Priority
Number:
884598 PDate:
11.1.2007Country:
US
Classification
Categories:
A61K 9/20